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Abstract: The dietary inflammatory index (DII®), a validated tool used to measure the inflammatory
potential of the diet, has been associated with metabolic disorders in various settings, but not
in African populations. The aim of this study was to investigate whether the DII is associated
with markers of type 2 diabetes (T2D) risk, and if this association is mediated by adiposity and/or
low-grade inflammation, in black South Africa women. Energy-adjusted-DII (E-DII) scores were
calculated in 190 women (median age, 53 years) from the Birth-to-Twenty plus cohort using a validated
food frequency questionnaire. Fasting glucose, insulin, HbA1c, and inflammatory cytokines were
measured, and an oral glucose tolerance test performed. Basic anthropometry and dual-energy x-ray
absorptiometry-derived body fat, including estimate of visceral adipose tissue (VAT) area, were
measured. E-DII scores were associated with all markers of T2D risk, namely, fasting glucose and
insulin, HbA1c, HOMA2-IR, two-hour glucose and Matsuda index (all p < 0.05). After adjusting for
age, measures of adiposity, but not inflammatory cytokines, mediated the association between E-DII
and markers of T2D risk (p < 0.05). Measures of central obesity had proportionally higher (range:
23.5–100%) mediation effects than total obesity (range: 10–60%). The E-DII is associated with T2D
risk through obesity, in particular central obesity, among black middle-aged South African women.
Keywords: DII; diet-induced inflammation; obesity; VAT; mediation; T2D risk; South African women
1. Introduction
The rapid increase in the prevalence of non-communicable diseases (NCDs), such as type 2
diabetes (T2D), has become a major health concern, particularly in developing countries, such as South
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Africa (SA) [1–3]. South Africa had a diabetes prevalence of 5.5% in 2017 [3]. In 2016, diabetes was the
second leading cause of mortality in SA after tuberculosis, accounting for 5.5% of all deaths in both
males and females [2]. When classified by sex, diabetes-attributed mortality was worse in females
(7.2%) than in males (4.0%), and ranked first and fifth as the cause of death in females and males in
2016, respectively [2].
The prevalence of obesity and insulin resistance (IR), major risk factors for T2D, is higher in
black SA women than in white SA women [4–6]. Of great concern is that urban black SA women
are at even greater risk of NCDs compared to their rural counterparts [7,8]. Urbanization, which is
often accompanied by unhealthy diets and low levels of physical activity, has been identified as the
main driver of obesity in developing countries [8–11]. Urban black SA women who follow a typical
Western diet characterized by a high intake of fat, sugar and processed meat, and low intake of fruit
and vegetables, are more susceptible to NCDs than rural black women who still follow a traditional
diet, which is high in fiber, fruit, vegetables and low in animal products [8,10,11].
The relationship between unhealthy diets and NCDs can be attributed to numerous factors, including
diet-induced inflammation [12,13]. Indeed, several studies suggest that unhealthy diets may be involved
in the pathogenesis of NCDs through their effects on increasing low-grade inflammation [12–14], while
healthier diets, such as the Mediterranean diet, which are high in fruits, vegetables and fish, are
associated with lower levels of inflammation [12,13,15]. Low-grade inflammation is characterized by
high circulating levels of pro-inflammatory cytokines, such as c-reactive protein (CRP), tumor necrosis
factor- alpha (TNF-α), interleukins (e.g., IL-6), and infiltration of macrophages in insulin-dependent
tissues, which may lead to IR and, subsequently, to T2D [16,17].
The dietary inflammatory index (DII®), is a literature-derived dietary tool that measures the
inflammatory potential of an individual’s diet [14]. Participants with higher DII (i.e., positive values)
scores are categorized as having a more pro-inflammatory diet and those with lower DII (i.e., negative
values) score represent a more anti-inflammatory diet [14]. The DII has been validated with several
inflammatory markers, such as CRP and interleukins [18]; and has recently been associated with
markers of glycaemia, namely, fasting glucose, HbA1c, post-load glucose and IR in non-African
populations [19–21].
Moreover, participants with higher DII scores were at greater risk of developing prediabetes and
T2D compared to participants with lower DII scores [20,21]. Notably, the association between DII
and markers of T2D has not been studied in a black African population, whose lifestyle (i.e., diet and
socioeconomic status (SES)) differs from white and Hispanic populations. SES (both low and high) and
sociocultural factors have thus, through their effects on unhealthy diets and eating behaviors, been
associated with NCD risk in black SA communities [22,23]. Furthermore, the black SA population
still experiences inadequate micronutrient intake [10,11], in particular micronutrients with putative
anti-inflammatory properties, such as vitamin A, niacin, iron and zinc. In contrast, energy intake
has not undergone any major change [10,11], suggesting that the quality of the diet, rather than the
quantity of food consumed, and changes in energy expenditure may explain the high obesity levels,
and, in turn, the susceptibility to T2D risk in urban black SA women.
Use of the DII may contribute to our understanding of the role of diet-induced inflammation
in the pathophysiology of T2D, while linking it to markers of low-grade inflammation and obesity.
Indeed, the DII has been associated with markers of low-grade inflammation and measures of adiposity
(i.e., BMI) and these risk factors have also been suggested to mediate the association between DII and
markers of T2D in non-African populations [19].
The aim of this study was to determine whether dietary-induced inflammation, measured by the
DII, is associated with markers of T2D risk, and if this association is mediated by adiposity and/or
inflammatory markers, in middle-aged and older black SA women.
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2. Materials and Methods
2.1. Study Design
This cross-sectional study was conducted between 2015 and 2016 and included 190 black female
caregivers of the original Birth to Twenty plus (BT20+) cohort, living in Soweto, Johannesburg [24].
The female caregivers were invited to participate if they fulfilled the following inclusion criteria: (1)
Female caregiver of the original cohort; (2) provided stored serum samples and blood analyte data
(criteria for the larger study); (3) less than 65 years of age; (4) HIV negative on testing; (5) not currently
pregnant or lactating. Of those tested (n = 221), nine women were excluded from the statistical analyses,
due to unreliable energy intake data (i.e., excessive energy intake (≥30,000 kJ), n = 4), lack of food
frequency questionnaire (FFQ) data (n = 2) and lack of blood samples (n = 3). Furthermore, 22 diabetic
participants (based on self-report and/or use of T2D medication) were excluded from the analyses,
resulting in a final sample size of 190 participants.
The study was approved by the Human Research Ethics Committee (Medical) of the University of
the Witwatersrand (M010556 and M150530). The procedures and risks associated with the study were
explained to the participants and they all signed the consent form prior to participation in the study. All
testing procedures were performed at the South African Medical Research Council (MRC)/University
of the Witwatersrand (WITS) Developmental Pathways for Health Research Unit (DPHRU) at the Chris
Hani Baragwanath Hospital in Soweto Johannesburg.
2.2. Body Composition
Weight and height were measured in subjects wearing only lightweight clothing and without
shoes, using a standard scale and stadiometer. Waist (level of umbilicus) and hip (largest gluteal area)
circumferences were measured in triplicate and the average was used for statistical analyses.
The International Diabetes Federation waist circumference (WC) threshold (women: 80 cm) was
used to calculate abdominal obesity (expressed as a percentage) [25]. BMI was calculated as weight
(kg)/height (m)2 and classified according to WHO criteria; underweight (<18.5 kg/m2), normal weight
(18.5–24.9 kg/m2), overweight (25–29.9 kg/m2), or obese (≥30 kg/m2) [26]. Whole body composition
was measured using dual energy x-ray absorptiometry (DXA; Hologic Discovery-W (S/N 71201),
Bedford, MA, USA; software version 13.4.2:7), and included subtotal (whole body minus head) fat
mass (expressed in kg and as a percentage of sub-total fat mass, %FM). Abdominal visceral adipose
tissue (VAT) was estimated using algorithms included in the DXA, and has been shown to correlate
with clinical computed tomography [27]. Body composition of participants exceeding the scan field
limits was calculated using the arm-replacement [28]. The coefficient of variations were 1% and <2%
for fat-free soft tissue mass and total fat mass, respectively.
2.3. Socio-Demographic Assessment
A demographic questionnaire, written in English, was administered in the participant’s language
of choice (i.e., English, IsiXhosa, IsiZulu, SeSotho, Sepedi, SeTswana, TshiVenda, XiTsonga, SiSwati)
and included measures of SES, including housing density, asset index, household food insecurity,
marital status, educational assessment, and employment. Housing density was defined as the number
of persons per room living in the household. Asset index was based on 12 items (e.g., motor vehicle,
washing machine, TV) reflecting individual and household wealth. Food insecurity was assessed
using a validated nine question Household Food Insecurity Access Scale [29]. The responses to the
nine-questionnaire scale are summed to create a food security score, with a maximum score of 27.
The higher the score the more food insecurity the household experienced, whereas the lower the score
the less food insecurity experienced in the past four weeks [29]. Education was categorized by grades
passed. Participants were categorized as being married or not, employed or unemployed. Moreover,
questions on lifestyle factors, including smoking and alcohol intake were recorded. Physical activity
and sedentary behavior were measured using ActiGraph GT3X-Plus triaxial accelerometers (ActiGraph
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GTX3+, ActiGraph LLC, Pensacola, Florida) and activPAL devices (activPAL3c, PAL Technologies Ltd.,
Glasgow, UK), respectively, as described previously [30].
2.4. The Dietary Inflammatory Index (DII®)
The DII scores for all the participants in the current study were calculated from the dietary
intake data collected using a seven-day food frequency questionnaire [31,32]. The development and
validation of the DII have been described in detail elsewhere [14,18]. The DII is a literature-derived,
validated tool used to measure the inflammatory potential of the diet based on extensive literature
search performed to identify peer-reviewed primary research articles published through 2010 that
reported the association between various dietary factors and six inflammatory markers (IL-1β, IL-4,
IL-6, IL-10, TNFα, and CRP). A total of 1943 qualifying articles were reviewed, indexed, and scored
to derive the component-specific inflammatory effect score for 45 dietary factors (i.e., components
of DII), comprising macronutrients and micronutrients, as well as some bioactive components [14].
These FFQ-derived food and nutrient intake data were first adjusted for total energy (i.e., per 1000
kilocalories) and standardized by creating a z score for each component using mean and standard
deviation data from a global energy-adjusted dietary database comprised of dietary intake from 11
populations living in different regions of the world. To reduce the effect of right-skewing the z scores for
each DII component were converted to proportions (i.e., values from 0 to 1) and then each proportion
was centered by doubling and subtracting 1. From this, the energy-adjusted standardized dietary
intake (expressed as centered proportions) was then multiplied by the corresponding literature-derived
inflammatory effect score for each DII component. Individual scores from each DII component were
then summed to determine the overall E-DII score for each individual [14]. A higher (i.e., more positive)
score indicates a more pro-inflammatory diet and a lower score (i.e., more negative) represents a more
anti-inflammatory diet. The DII scores can range between 7.98 (maximally pro-inflammatory) and
−8.87 (maximally anti-inflammatory) [14]. Steps involved in the DII calculations are described in
Figure 1.
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Figure 1. Sequence of steps in creating the energy-adjusted- DII (dietary inflammatory index) in
middle-aged black South African women.
For the current study, a total of 21 out of 45 food parameters were available in our dietary intake
database, and were thus used for the analysis of the DII score. The 21 food parameters included protein,
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fat, SFA, monounsaturated fatty acid (MUFA), polyunsaturated fatty acid (PUFA), carbohydrate,
cholesterol, alcohol, fiber, iron, magnesium, Zinc, vitamin A (retinol equivalent), thiamine, riboflavin,
niacin, vitamin B6, vitamin B12, vitamin C, vitamin D and vitamin E. Participants with E-DII scores
greater than 0 were classified as the positive E-DII group (reflecting pro-inflammatory diet; n = 83) and
those with E-DII scores less than 0 were classified as negative E-DII group (indicating anti-inflammatory
diet; n = 107). There were no participants with E-DII score equal to 0.
2.5. Biochemical Analysis
Blood samples were drawn in the fasted state (12 hours, overnight) for the subsequent
determination of glycated hemoglobin (HbA1c), plasma glucose and serum insulin concentrations.
Thereafter, all participants completed a standard oral glucose tolerance test (OGTT). In brief, participants
ingested 75g of anhydrous glucose dissolved in 250 mL water, within 5 minutes. Following the glucose
ingestion, blood samples were taken at 30, 60, 90 and 120 min. The samples were centrifuged at 3000 rpm
for 10 min at 4 ◦C, the plasma was stored at −20 ◦C for subsequent analysis of glucose concentrations,
and the serum was stored at−80 ◦C for the analysis of insulin concentrations and inflammatory markers.
Plasma glucose concentrations were analyzed on the Randox RX Daytona Chemistry Analyzer using
enzymatic methods (Randox Laboratories Ltd., London, UK). Serum insulin assays were analyzed on
the Immulite® 1000 Immunoassay System (Siemens Chemiluminescent Healthcare GmbH, Henkestr,
Germany). HbA1c levels were measured on whole blood samples using the D-10™ Hemoglobin
Analyzer (Bio-Rad Laboratories, Inc. Hercules, CA, USA). Inflammatory cytokines, namely, IL-6, IL-1ra,
IL-8, IL-10, IL15, monocyte chemotactic protein (MCP)1, interferon (IFN) gamma, and TNF-α were
measured using Milliplex MAP MAG Human Cytokine kit (Merck, Johannesburg, South Africa) and
xMAP technology (Luminex, Austin, Texas) according to the manufacturer’s instructions. Out of the
eight cytokines measured, only TNF-α, 1L-8 and MCP-1 were detectable in all the samples, while the
rest were below the detectable range, and therefore not included in the analyses.
Insulin resistance (IR) was calculated from fasting glucose and insulin using the Homeostasis
Model Assessment (HOMA2-IR) calculator v2.2.3 [33]. Fasting and OGTT glucose and insulin data
(0, 30, 60, 90 and 120) were used to calculate insulin sensitivity using the Matsuda Index web
calculator [34]. Participants with missing glucose and insulin data from the OGTT (n = 17) were
excluded from this parameter.
2.6. Statistical Analysis
The Shapiro-Wilk test was used to assess the distribution of continuous variables. Normally
distributed data are presented as mean ± standard deviation (SD), skewed variables are represented as
medians and 25th–75th percentiles, and categorical data are presented as frequency (%). Moreover,
Levene’s robust test was used to test for equal variance between groups. Differences in measures
of SES, lifestyle/behavioral factors, body composition and markers of T2D risk between the positive
and negative E-DII groups were examined using the Student’s t test and the Wilcoxon rank-sum
(Mann-Whitney), or the Chi square test or Fisher exact test as appropriate. To determine whether
the E-DII was associated with markers of T2D risk (fasting glucose and insulin, HbA1c, HOMA2-IR,
two-hour glucose and OGTT-derived insulin sensitivity), or whether the association was mediated by
adiposity (WC, BMI, VAT and body fat mass) and/or inflammatory markers (TNF-α, IL-8 and MCP-1),
a simple mediation analysis was completed (Figure 2a,b) [35]. In each model, an independent, a
dependent and a mediator variable were included in order to calculate the unstandardized regression
coefficients and generate three outputs, namely, total, direct and indirect effects [36]. Path c, represents
the simple total effect of E-DII on markers of T2D without adjusting for mediators (Figure 2a). Path α
represents the regression coefficient between the independent variable (i.e., E-DII) and the mediator
variable (e.g., VAT) (Figure 2a). The regression coefficient of Path β represents the effect of the mediator
variable on the markers of T2D (Figure 2b). The product of regression coefficients α and β (αβ)
represents the mediated effect (indirect effect) of E-DII on markers of T2D through the mediator variable
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(Figure 2b). Path c’ represents the direct effect of E-DII on markers of T2D after controlling for the
effect of the mediator (Figure 2b).
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single mediation analysis models were adjuste for age. All data were analyzed using Stata® (Version
13.1, Statcorp, College Stati n, TX, USA). A test was considered statistically significant if p ≤ 0.05.
3. Results
3.1. Participants’ Characteristics According to E-DII Score
The median (25th–75th percentiles) age of the total sample was 53 (48–59) years. The E-DII ranged
from +1.92 (most pro-inflammatory) to −2.51 (most anti-inflammatory). Participants were grouped
based on whether they had a positive (n = 83; 43.7%) or negative (n = 107; 56.3%) E-DII score (Table 1).
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Table 1. Body composition and clinical characteristics of the participants according to E-DII scores.
Overall Negative E-DII Group (n = 107) Positive E-DII Group (n = 83) p Value
E-DII score (minimum-maximum value) −2.51–1.92 −2.51–0.01 0.01–1.92
E-DII −0.2 ± 1.0 −0.9 ± 0.6 0.6 ± 0.5
Age (years) 53 (48–59) 54 (49–59) 54 (49–60) 0.87
Anthropometry
Height (m) 1.6 ± 0.1 1.6 ± 0.1 1.6 ± 0.1 0.93
Weight (kg) 84.7 (73.6–96.8) 84.0 (70.4–94.2) 87.2 (76.4–100.2) 0.15
BMI (kg/m2) 33.5 (29.8–38.8) 33.5 (29.0–37.2) 34.2 (30.2–40.1) 0.23
BMI categories, n (%)
Normal weight 18 (9.5) 10 (9.4) 8 (9.6)
0.46Overweight 30 (15.8) 20 (18.7) 10 (12.1)
Obese 142 (74.7) 77 (72.0) 65 (78.3)
Waist circumference (cm) 100.1 ± 13.0 98.3 ± 12.3 102.4 ± 13.7 0.03
Waist circumference-abdominal obesity, n (%)
Waist circumference (≥80 cm) 177 (93.2) 100 (93.5) 77 (92.8)
0.85
Waist circumference (<80 cm) 13 (6.8) 7 (6.5) 6 (7.2)
Hip circumference (cm) 121.8 ± 14.5 121.0 ± 14.3 122.9± 14.7 0.21
WHR 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 0.04
Body composition and body fat distribution
Body Fat mass (kg) 39.6 (31.5 –48.2) 38.7 (29.8–46.6) 40.9 (33.1–50.8) 0.12
Body fat (%) 50.7 (46.2–54.0) 50.1 (44.8–53.8) 51.5 (47.0–54.6) 0.09
VAT area (cm2) 165 ± 62 155 ± 59 178 ± 64 0.01
SAT area (cm2) 507 ± 157 495 ± 154 521 ± 161 0.27
Clinical biomarkers
Fasting glucose (mmol/L) 4.9 (4.3–5.5) 4.8 (4.3–5.4) 5.1 (4.3–5.7) 0.07
Fasting insulin (mUI/mL) 10.4 (5.7–18.0) 9.8 (5.7–15.7) 11.7 (5.9–18.9) 0.27
Two-hour glucose (mmol/L) 6.7 (5.3–8.1) 6.3 (5.3–7.8) 7.2 (6.0–8.6) 0.02
HbA1c (%) 5.5 (5.1–5.7) 5.4 (5.1–5.7) 5.5 (5.2–5.8) 0.48
HOMA2-IR 1.5 (0.8–2.6) 1.4 (0.8–2.2) 1.7 (0.8–2.7) 0.23
Matsuda Index (OGTT-derived insulin sensitivity) 3.6 (2.1–6.0) 3.9 (2.4–6.1) 2.9 (1.9–5.6) 0.10
TNF-α (pg/mL) 11.0 (8.0–15.1) 9.9 (7.8–14.2) 12.1 (8.7–16.7) 0.03
IL-8 (pg/mL) 5.4 (2.4–11.4) 4.8 (2.6–8.9) 6.3 (2.2–12.6) 0.16
MCP-1 (pg/mL) 436.2(325.2–627.5) 449.9 (321.2–664.7) 422.6 (330.1–595.7) 0.71
Data presented as means ± SD or median (25th–75th percentiles). BMI, body mass index; DII, dietary inflammatory index; HbA1c, glycated hemoglobin; HOMA2-IR, Homeostasis Model
Assessment- insulin resistance; IL-8; Interleukin-8, MCP-1, monocyte chemotactic protein 1; OGTT, oral glucose tolerance test. SAT, subcutaneous adipose tissue; TNF-α, tumor necrosis
factor alpha; VAT, visceral adipose tissue; WC, waist circumference; WHR, waist-to-hip ratio.
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While BMI and total body fat did not differ between groups, waist circumference, WHR and
VAT were higher in the positive E-DII group compared to the negative E-DII group. Furthermore,
participants with a positive E-DII score had higher two-hour glucose and TNF-α levels than those
with a negative E-DII score (p < 0.05). There were no significant differences in any of the fasting or
OGTT-derived measures of T2D risk, and inflammatory markers (IL-8 and MCP-1) did not differ
between the groups (Table 1).
Comparisons of measures of SES and lifestyle/behavioral factors, and nutrient intakes between the
two E-DII score groups are presented in Tables S1 and S2, respectively. There were no differences in any of
the measures of SES and lifestyle/behavioral factors, including physical activity and sedentary behaviors
between the two E-DII score groups (Table S1). A median score of 9 out of 12 possible household
items (e.g., motor vehicle and washing machine) was reported for the participants. Furthermore,
the participants scored an average of 4 (range: 0–9) on the Household Food Insecurity Access Scale,
indicating that the participant/household experienced less food insecurity for the measured period.
Energy and carbohydrate intake (except when carbohydrate is expressed as a percentage of energy
intake), alcohol and cholesterol levels did not differ between groups (Table S2). In contrast, protein
was lower, but total fat, SFA, MUFA and PUFA (both in grams and percentage of energy intake) were
higher in the positive E-DII score group than the negative E-DII score group (all p < 0.05) (Table S2).
Vitamins A, B12 and D, and riboflavin did not differ between the groups, whereas fiber intake and
the rest of the minerals (e.g., iron, magnesium and zinc) and vitamins (e.g., vitamin B6, C and E) were
lower in the positive DII score compared to the negative DII score group (p < 0.05) (Table S2).
3.2. Associations between E-DII and Markers of T2D Risk in Black SA Women
The unstandardized regression coefficients of the total effect of E-DII on markers of T2D risk
without (Path c) and with body composition and inflammatory cytokines as mediators (Path c’) are
presented in Tables 2 and 3, respectively. All the models were adjusted for the potential effects of
age. E-DII was positively associated with all markers of T2D risk, namely, fasting glucose and insulin,
HbA1c, HOMA2-IR, two-hour glucose levels and Matsuda Index (i.e., OGTT-derived insulin sensitivity)
(all p < 0.05).
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Table 2. Direct and indirect effects of E-DII on markers of T2D risk with body composition as mediators in black South African (SA) women.
Variables Total Effect (c) Direct Effect (c’) Indirect Effect (αβ) Proportion ofMediation
Mediators and Outcomes Estimate (95%CI) p-Value Estimate (95%CI) p-value 95%CI p-value %
Fasting glucose (mmol/L) 0.17 (0.01–0.34) 0.04
via waist circumference (cm) 0.12 (−0.07–0.32) 0.21 0.04 (−0.03–0.12) 0.25 23.5
via BMI (kg/m2) 0.13 (−0.05–0.32) 0.16 0.04 (−0.03–0.10) 0.28 23.5
via VAT (cm2) 0.07 (−0.10–0.24) 0.42 0.10 (0.00–0.20) 0.04 58.8
via body fat mass (kg) 0.14 (−0.05–0.33) 0.14 0.03 (−0.03–0.08) 0.371 17.6
Fasting insulin (mUI/mL) 1.70 (0.45–2.96) 0.008
via waist circumference (cm) 0.38 (−0.87–1.63) 0.55 1.32 (0.40–2.25) 0.005 77.6
via BMI (kg/m2) 0.71 (−0.51–1.93) 0.26 0.99 (0.20–1.78) 0.01 58.2
via VAT (cm2) 0.08 (−1.19–1.35) 0.90 1.62 (0.60–2.64) 0.002 95.3
via body fat mass (kg) 0.89 (−0.30–2.09) 0.14 0.81 (0.11–1.51) 0.02 47.6
HbA1c (%) 0.10 (0.01–0.18) 0.02
via waist circumference (cm) 0.07 (−0.02–0.15) 0.14 0.03 (−0.00–0.06) 0.07 30.0
via BMI (kg/m2) 0.08 (−0.01–0.16) 0.08 0.02 (−0.01–0.05) 0.13 20.0
via VAT (cm2) 0.05 (−0.02–0.14) 0.18 0.04 (0.00–0.08) 0.04 40.0
via body fat mass (kg) 0.08 (−0.00–0.17) 0.06 0.01 (−0.01–0.04) 0.19 10.0
HOMA2-IR 0.25 (0.07–0.44) 0.008
via waist circumference (cm) 0.05 (−0.15–0.26) 0.59 0.20 (0.05–0.35) 0.009 80.0
via BMI (kg/m2) 0.10 (−0.09–0.30) 0.30 0.15 (0.02–0.28) 0.02 60.0
via VAT (cm2) 0.00 (−0.20–0.21) 0.97 0.25 (0.08–0.41) 0.003 100.0
via body fat mass (kg) 0.13 (−0.05–0.32) 0.16 0.12 (0.01–0.23) 0.03 48.0
Two-hour glucose (mmol/L) 0.48 (0.10–0.86) 0.01
via waist circumference (cm) 0.34 (−0.08–0.76) 0.11 0.14 (−0.01–0.028) 0.06 29.2
via BMI (kg/m2) 0.39 (−0.02–0.81) 0.06 0.09 (−0.04–0.21) 0.17 18.8
via VAT (cm2) 0.21 (−0.15–0.56) 0.26 0.27 (0.08–0.47) 0.006 56.3
via body fat mass (kg) 0.42 (0.00–0.83) 0.05 0.06 (−0.04–0.17) 0.27 12.5
Matsuda Index * 0.05 (0.02–0.09) 0.003
via waist circumference (cm) 0.01 (−0.04–0.06) 0.62 0.04 (0.00–0.08) 0.03 80.0
via BMI (kg/m2) 0.02 (−0.02–0.07) 0.31 0.03 (−0.00–0.06) 0.05 60.0
via VAT (cm2) −0.01 (−0.06–0.05) 0.85 0.05 (0.01–0.10) 0.01 100.0
via body fat mass (kg) 0.03 (−0.01–0.07) 0.16 0.02 (−0.00–0.05) 0.08 40.0
Regression coefficients c, α, β and c’ are shown in Figure 1a,b. All estimates were adjusted for the potential effects of age. BMI, body mass index; DII, dietary inflammatory index; HbA1c,
glycated hemoglobin; HOMA2-IR, Homeostasis Model Assessment- insulin resistance; VAT, visceral adipose tissue. * Matsuda index was modelled as an inverse variable in order to
calculate the proportion of mediation effect, thus the regression coefficients are positive instead of negative.
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Table 3. Total, direct and indirect effects of E-DII on markers of T2D risk with inflammatory cytokines as mediators in black SA women.
Variables Total Effect (c) Direct Effect (c’) Indirect Effect (αβ)
Mediators and Outcomes Estimate (95%CI) p-Value Estimate (95%CI) p-Value Estimate (95%CI) p-Value
Fasting glucose (mmol/L) 0.17 (0.01–0.34) 0.04
via TNF-α (pg/mL) 0.16 (−0.01–0.33) 0.07 0.01 (−0.01–0.04) 0.28
via IL-8 (pg/mL) 0.17 (0.01–0.34) 0.04 −0.00 (−0.01–0.01) 0.71
via MCP-1 (pg/mL) 0.16 (0.01–0.32) 0.04 0.01 (−0.01–0.03) 0.43
Fasting insulin (mUI/mL) 1.70 (0.45–2.96) 0.008
via TNF-α (pg/mL) 1.55 (0.32–2.78) 0.01 0.15 (−0.06–0.36) 0.17
via IL-8 (pg/mL) 1.72 (0.47–2.97) 0.007 −0.02 (−0.14–0.11) 0.77
via MCP-1 (pg/mL) 1.66 (0.43–2.88) 0.008 0.04 (−0.13–0.21) 0.63
HbA1c (%) 0.10 (0.01–0.18) 0.02
via TNF-α (pg/mL) 0.11 (0.02–0.19) 0.01 −0.01 (−0.02–0.00) 0.15
via IL-8 (pg/mL) 0.10 (0.02–0.18) 0.02 −0.00 (−0.01–0.00) 0.49
via MCP-1 (pg/mL) 0.10 (0.02–0.18) 0.02 −0.00 (−0.01–0.01) 0.92
HOMA2-IR 0.25 (0.07–0.44) 0.008
via TNF-α (pg/mL) 0.23 (0.05–0.41) 0.02 0.02 (−0.01–0.06) 0.15
via IL-8 (pg/mL) 0.26 (0.07–0.44) 0.007 −0.00 (−0.02–0.02) 0.75
via MCP-1 (pg/mL) 0.25 (0.07–0.43) 0.007 0.01 (−0.02–0.03) 0.59
Two-hour glucose (mmol/L) 0.48 (0.10–0.86) 0.01
via TNF-α (pg/mL) 0.46 (0.07–0.85) 0.02 0.02 (−0.02–0.07) 0.31
via IL-8 (pg/mL) 0.49 (0.11–0.87) 0.01 −0.01 (−0.04–0.01) 0.42
via MCP-1 (pg/mL) 0.46 (0.08–0.83) 0.02 0.03 (−0.04–0.09) 0.41
Matsuda Index * 0.05 (0.02–0.09) 0.003
via TNF-α (pg/mL) 0.05 (0.01–0.08) 0.007 0.00 (−0.00–0.01) 0.23
via IL-8 (pg/mL) 0.05 (0.02–0.09) 0.003 −0.00 (−0.00–0.00) 0.61
via MCP-1 (pg/mL) 0.05 (0.02–0.09) 0.003 0.00 (−0.00–0.01) 0.67
Regression coefficients α, β and c’ are shown in Figure 2a,b. All estimates were adjusted for the potential effects of age. DII, dietary inflammatory index; HbA1c, glycated hemoglobin;
HOMA2-IR, Homeostasis Model Assessment- insulin resistance; IL-8; Interleukin-8, MCP-1, monocyte chemotactic protein 1; TNF-α, tumor necrosis factor alpha. * Matsuda index was
modelled as an inverse variable in order to calculate the proportion of mediation effect, thus the regression coefficients are positive instead of negative.
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The association between the proposed mediators and E-DII (path α) are presented in Table 4, while
the associations between the potential mediators and the outcome, markers of T2D risk (path β), are
presented in Table 5. Path α showed that E-DII had a significant association with all body composition
measures, whereas only TNF-α associated with E-DII among the pro-inflammatory cytokines (Table 4).
Analysis of Path β, showed that all the body composition measures were significantly associated with
fasting insulin, HOMA2-IR and Matsuda Index Table 5). Furthermore, both WC and VAT (measures of
central obesity) were positively associated with HbA1c and two-hour glucose load, with only VAT
significantly associated with fasting glucose. In contrast, none of the inflammatory cytokines were
significantly associated with markers of T2D risk (Table 5).
Table 4. Regression coefficients (95% CIs) for the association between E-DII and measures of body
composition and inflammatory cytokines in black SA women.
Mediator Variables Estimate 95%CI p-Value
Waist circumference (cm) 3.27 1.39–5.16 0.001
BMI (kg/m2) 1.54 0.52–2.55 0.003
VAT area (cm2) 16.88 8.30–25.46 <0.0001
Body fat mass (kg) 2.49 0.65–4.32 0.008
TNF-α (pg/mL) 0.98 0.13–1.82 0.02
IL-8 (pg/mL) 0.98 −1.09–3.01 0.36
MCP-1 (pg/mL) 25.73 −17.47–68.92 0.24
Estimates for the association between E-DII and body composition and inflammatory cytokines represent the
regression coefficients for Path α Figure 2b. All estimates were adjusted for the potential effects of age. BMI, body
mass index; DII, dietary inflammatory index; IL-8; Interleukin-8, MCP-1, monocyte chemotactic protein 1; TNF-α,
tumor necrosis factor alpha; VAT, visceral adipose tissue.
Nutrients 2019, 11, 1246 13 of 19
Table 5. Regression coefficients (95% CIs) for the associations between body composition and inflammatory cytokines and markers of T2D risk in black SA women.
Fasting Glucose Fasting Insulin HbA1c
Estimate 95%CI p-Value Estimate 95%CI p-Value Estimate 95%CI p-Value
Waist circumference (cm) 0.01 −0.01–0.03 0.22 0.40 0.23–0.57 <0.0001 0.01 0.00–0.02 0.04
BMI (kg/m2) 0.02 −0.02–0.06 0.25 0.65 0.34–0.95 <0.0001 0.01 −0.00–0.03 0.09
VAT area (cm2) 0.01 0.00–0.01 0.02 0.10 0.06–0.13 <0.0001 0.00 0.00–0.00 0.02
Body fat mass (kg) 0.01 −0.01–0.03 0.33 0.33 0.17–0.48 <0.0001 0.01 −0.00–0.01 0.14
TNF-α (pg/mL) 0.01 −0.01–0.03 0.20 0.15 −0.04–0.34 0.11 −0.01 −0.02–0.00 0.06
IL-8 (pg/mL) −0.00 −0.01–0.01 0.63 −0.02 −0.13–0.09 0.73 −0.00 −0.01–0.00 0.14
MCP-1 (pg/mL) 0.00 −0.00–0.00 0.29 0.00 −0.00–0.01 0.56 −0.00 −0.00–0.00 0.92
HOMA2-IR Two-Hour Glucose Matsuda Index *
Estimate 95%CI p-Value Estimate 95%CI p-Value Estimate 95%CI p-Value
Waist circumference (cm) 0.06 0.03–0.09 <0.0001 0.04 0.01–0.08 0.03 0.01 0.00–0.02 0.008
BMI (kg/m2) 0.10 0.04–0.15 <0.0001 0.06 −0.01–0.12 0.10 0.02 0.00–0.03 0.02
VAT area (cm2) 0.01 0.01–0.02 <0.0001 0.02 0.01–0.02 <0.0001 0.00 0.00–0.00 0.001
Body fat mass (kg) 0.05 0.02–0.08 <0.0001 0.03 −0.01–0.06 0.20 0.01 0.00–0.01 0.03
TNF-α (pg/mL) 0.02 −0.00–0.05 0.10 0.03 −0.02–0.07 0.26 0.00 −0.00–0.01 0.13
IL-8 (pg/mL) −0.00 −0.02–0.01 0.70 −0.01 −0.03–0.01 0.19 −0.00 −0.00–0.00 0.39
MCP-1 (pg/mL) 0.00 −0.00–0.00 0.49 0.00 −0.00–0.00 0.16 0.00 −0.00–0.00 0.58
Regression coefficients correspond to Path β in Figure 2b. All estimates were adjusted for the potential effects of age. BMI, body mass index; DII, dietary inflammatory index; HbA1c,
glycated hemoglobin; HOMA2-IR, Homeostasis Model Assessment- insulin resistance; IL-8; Interleukin-8, MCP-1, monocyte chemotactic protein 1; TNF-α, tumor necrosis factor alpha;
VAT, visceral adipose tissue. * Matsuda index was modelled as an inverse variable in order to calculate the proportion of mediation effect, thus the regression coefficients are positive
instead of negative.
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3.3. Associations between E-DII and Markers of T2D Risk in Black SA Women with Body Composition as
Mediators
The direct (Path c’) and indirect effects (product of Paths α and β, αβ) of E-DII on markers of
T2D risk, through body composition, including the proportion of mediation by the body composition
measures also are presented in Table 2. A consistent finding was that VAT was a significant mediator
of the association between E-DII and all markers of T2D risk, including fasting glucose and insulin,
HbA1c, HOMA2-IR, two-hour glucose and Matsuda Index (all p < 0.05). Both WC and BMI mediated
the association between E-DII and fasting insulin, HOMA2-IR and Matsuda Index (all p < 0.05). Body
fat mass mediated the association between E-DII and fasting insulin and HOMA2-IR (all p < 0.05).
The proportion of the effect mediated by measures of central obesity (i.e., VAT and WC) was higher
(23.5–100%) than the proportion mediated by measures of total obesity, including BMI and body fat
mass (10–60%). Notably, VAT mediated most of the association between E-DII and markers of T2D
risk, in particular for measures of insulin resistance (HOMA2-IR) and sensitivity (Matsuda Index)
(proportion of mediation: 100%). Furthermore, the proportion of the mediation effect for HOMA2-IR
and Matsuda Index was higher (40–100%) than for measures of glucose tolerance (e.g., fasting and
two-hour glucose load). For instance, the mediating effects on the association between E-DII and
HOMA2-IR were: For VAT (100.0%), WC (80.0%), BMI (60.0%) and body fat mass (48.0%) (Table 2).
Direct effects (Path c’) between E-DII and T2D markers were not significant after adjusting for WC,
BMI and VAT (Table 2). Similar findings were reported for body fat mass, except for the association
between E-DII and two-hour glucose load.
3.4. Direct and Indirect effects of E-DII on Markers of T2D in Black SA Women with Inflammatory Cytokines
As Mediators
The associations between E-DII and markers of T2D before and after adjustment for the effect of
inflammatory cytokines on T2D risk are shown in Table 3. The inflammatory cytokines did not have any
significant mediating effect on the association between E-DII and markers of T2D risk (Table 3). After
adjusting for the inflammatory markers, E-DII was directly associated with fasting glucose (except for
TNF-α) and insulin, HbA1c, HOMA2-IR, two-hour glucose load and Matsuda Index (Table 3) (p < 0.05).
4. Discussion
This is the first study, to our knowledge, to suggest a link between diet-associated inflammation,
as assessed by E-DII, and markers of T2D in a sample of middle-aged black SA women. Notably,
we show that this association is mediated by adiposity, in particular central obesity (VAT and WC).
Accordingly, measures of central adiposity were higher in participants with a positive E-DII score,
reflecting a pro-inflammatory diet, compared to those with a negative E-DII score, which reflected
an anti-inflammatory diet. While circulating TNF-α concentrations were higher in the positive E-DII
group than the negative E-DII group, circulating inflammatory markers did not mediate the association
between E-DII and markers of T2D in middle-aged black SA women.
Typical components of a Western diet, including high intakes of fat and red meat, and low intakes
of vitamin A-rich fruit and vegetables, are linked to inflammation and a higher E-DII score [12,13] and
have been associated with T2D and CVD risk in urban black SA populations [9–11]. These results
suggest that pro-inflammatory foods are part of the habitual diet of urban black SA populations, and
thus implicated in the pathophysiology of T2D in this population. Although the exact biological
mechanisms implicated in the association between diet-induced inflammation and the development
of T2D are not fully understood, we propose that excessive intake of pro-inflammatory foods may
enhance fat accumulation, increase total and central obesity, in particular VAT, and subsequently
induce an inflammatory profile, which is often reported in an obese state [16,17,37]. To substantiate
this notion, the direct associations between E-DII and markers of T2D, after adjusting for measures of
body composition, in particular VAT, were no longer significant. In contrast, the direct associations
between E-DII and markers of T2D remained significant, after adjusting for the inflammatory cytokines.
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This suggests that a pro-inflammatory diet has a close association with measures of obesity, in particular
for pro-inflammatory adipose tissues, such as VAT, and that the presence of obesity is more detrimental
than that of low-grade inflammation in the development of T2D risk in this population.
Furthermore, the proposed mechanism for the development of an obese and/or inflammatory
state in the presence of a pro-inflammatory diet is supported by the significantly higher measures of
central adiposity and TNF-α levels in the positive E-DII score group compared to the negative E-DII
group. Accordingly, obesity, in particular central obesity-related inflammation, has been implicated in
the development of T2D [16,17,38]. In line with these findings, we reported that VAT mediated most
of the association between E-DII and markers of T2D in comparison to other measures of adiposity.
The higher proportion of mediation by measures of central obesity, in particular VAT, compared to
measures of total adiposity (BMI as a proxy) might be explained by VAT having a higher inflammatory
profile and higher rates of lipolysis than other adipose tissue sites [36,39,40]. Further, the anatomical
position of VAT relative to the liver, leading to delivery of excess free fatty acids and pro-inflammatory
cytokines (e.g., TNF-α) via the hepatic portal system directly to the liver will impair hepatic insulin
signaling [36,39,40]. Indeed, ectopic fat accumulation in the liver has been shown to impair many
biological functions of the liver, and has been associated with hepatic IR, increased hepatic glucose
production and reduced insulin-stimulated hepatic glucose uptake, thus increased risk for T2D [38–40].
Our finding that the association between diet-induced inflammation (assessed by the E-DII) and
the risk of developing T2D is mediated by adiposity is notable, as only one study, to our knowledge,
has reported both adiposity and low-grade inflammation as mediators in the association between
diet-induced inflammation and markers of T2D in a European population [19]. However, the two
studies are not easily comparable as two different versions of the DII were used; we used a new version
of the DII with the updated scoring algorithm. Nonetheless, in our study, low-grade inflammation
did not mediate the association between E-DII and markers of T2D. This can be explained by the
non-significant association between inflammatory cytokines and markers of T2D risk, thus making
a mediation effect “impossible”. Moreover, we used three separate inflammatory cytokines, while a
total/summary score of six inflammatory cytokines, including CRP, IL-6, 1L-8 and TNF-α was used as
a marker of low-grade inflammation in the previous study [19].
Interestingly, out of the three inflammatory cytokines used in our analyses, only TNF-α was
significantly different between the positive and negative E-DII score groups, and it also was associated
with the E-DII score. TNF-α is the most highly secreted cytokine during obesity and was the first
inflammatory cytokine linking obesity-induced inflammation to IR [41,42]. This suggests that TNF-α
is a more prominent biomarker of obesity-induced inflammation than 1L-8 and MCP-1, in particular
for this population, with high levels of obesity. However, the non-significant association between
TNF-α and markers of T2D risk suggests that TNF-α (and other inflammatory cytokines) may not be
directly associated with markers of T2D risk in this population or their effects might be diminished
in the presence of more detrimental risk factors, such as obesity. Accordingly, it was reported that,
despite a higher inflammatory profile at the genetic, adipose and circulating level, inflammation may
not be the main driver of the higher T2D risk in black populations [43]. However, inflammation acts
via paracrine and autocrine effects, limiting our ability to measure their specific effects. Nonetheless,
results from our study and others suggest that other risk factors, such as body fat and its distribution,
SES and lifestyle factors, including physical activity, as well as their interactions may be relatively more
important risk factors for T2D in this population.
In our study the E-DII score ranged from −2.51 to +1.92, which is narrower than that reported in a
previous study of T2D (−5.49 to + 4.12) [21]. The differences in the E-DII range between our study
and the previous study may be explained by numerous factors, including differences in sample size,
age, gender representation, type and number of food-parameters used in the calculation of the DII
score and quantity of the food-parameters consumed. We also propose that the narrow range in the
E-DII score might be explained by the homogeneity of the sample, in terms of SES and socio-cultural
background (i.e., eating similar foods and calorically similar amounts), thus resulting in a low variety
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of the diet, especially when taking into account energy intake. Furthermore, it is also important to note
that SES factors were not significantly different between the positive and negative E-DII score groups,
implying that other external factors (e.g., socio-cultural factors) might be contributing to the pro- and
anti-inflammatory profile of the diet. Furthermore, those individuals consuming a pro-inflammatory
diet are at high risk of developing T2D, in particular those with central obesity.
This is the first study to investigate diet-associated inflammation in relation to T2D risk, in
a high-risk and understudied African population, whose lifestyle differs from other populations.
Importantly, we used DXA to provide a more accurate and objective measure of whole-body composition,
including estimates of VAT. Despite its strengths, our study has potential limitations. This is a
cross-sectional study, thus our results do not imply causality. Also, only three out of the eight possible
inflammatory cytokines were detected in all the samples and used in the analysis, thus reducing
the chance of finding significant results. Furthermore, the dietary intake was measured at a single
time point, thus might not reflect the long-term or seasonal changes in dietary intake and lifestyle
activities of the participants. In an attempt to control and reduce the confounding effects of total
energy intake between the participants, the DII was adjusted per 1000 calories. Another potential
weakness of the study is the use of only 21 food parameters out of 45 for the analysis of the DII
score. However, the majority of earlier studies have not used all 45 food parameters [13,20,21].
For example, both Vahid et al. [20] and Denova-Gutierrez et al. [21] who have shown positive
associations between DII and prediabetes or T2D risk used 27 food items out of the possible 45 food
parameters. Nonetheless, positive associations between DII and inflammation have been reported
even with fewer food parameters [13,20,21], supporting the robustness of the DII in investigating
the association between diet-induced inflammation and inflammatory-related diseases. Furthermore,
E-DII takes into account the entire diet of the individual and measures its inflammatory potential [14],
making it a better tool compared to other dietary tools that only consider dietary patterns/food-groups
and single-nutrients. Nonetheless, the DII score was calibrated against a global dietary database that
did not include an African population [14]; which may not capture the true inflammatory profile of
an African diet. Future refinements of the DII might include expansion of the global comparative
database, which may help to capture even greater dietary diversity between populations.
5. Conclusions
In conclusion, our findings suggest that a pro-inflammatory diet may exacerbate the effects
of obesity, in particular central obesity, and that a pro-inflammatory diet may increase the risk of
developing T2D. Therefore, the promotion of healthy eating might prevent or reduce central obesity
and obesity-induced inflammation, and subsequently lower the risk of developing T2D in black
middle-aged black SA women.
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